Hashish for corona virus


It looks very bleak in the American healthcare system right now. Health care costs in the US have been increasing every year, and I've been saying for years that the US health system will implode on itself. With the spread of the corona virus, it becomes clear that this is the straw that breaks the camel's back. Hospitals will be overwhelmed with sick patients who die from coronavirus.

It's a good time to discuss how cannabis can come in handy for those patients who can't get beds in the intensive care unit. Some of them will die at home, and cannabis can be a lifesaver.

But first, let's discuss the risks of cannabis use at this point. Obviously, patients who inhale cannabis products tend to share their vape pens and joints. It is a terrible idea. Cannabis is a social drug and it is not advisable to make contacts at this time. We have to maintain social distance and use our own products, not others. Inhaling cannabis makes us susceptible to coughing and the spread of germs in the air. Make sure you cover your mouth with your elbow or handkerchief to prevent the coronavirus from being aerosolized around you to infect others.

However, cannabis can come in handy at a time when the corona virus is ready to kill us. We have no medications to treat the coronavirus, only those that relieve the symptoms. The virus kills us through a complex series of immune responses that lead to sepsis. When a patient goes through sepsis, their immune system releases chemicals that spread throughout the body and have serious consequences. Small amounts of inflammation in the body are helpful in healing and preventing the spread of infections, but massive systemic inflammation kills us. Our vessels choose, our organs fail and we die of an inflammatory overload. This happens to victims of the corona virus.

Cannabis contains THC, its active ingredient. THC binds CB1 receptors in the brain, which makes us high. THC also binds CB2 receptors to immune system cells, such as white blood cells. When cannabis activates CB2 receptors, it modulates the immune system's response and reduces the amount of inflammatory chemicals released. It is an anti-inflammatory drug like no other. Cannabis has been studied very minimally due to the ban on government-funded research, and we have few studies to base the treatment on. In such situations, however, we can use the theoretical mechanisms of drugs to hypothesize how they can benefit or harm. We know that cannabis has never killed anyone and we know that it has immune system effects that can be beneficial in times of sepsis. This January article explains some of these mechanisms.

When I was a hospital doctor and resident in internal medicine, I started treating patients in the intensive care unit with synthetic THC. The drug, which is legal and corresponds exactly to the THC, is called dronabinol and has been approved by the FDA since the 1990s. I would give this drug to patients I could not improve in the intensive care unit. Suddenly they would eat more and react to their families. It would help them enough to take them from the intensive care unit to the medical floors to release them to nursing homes and return to normal life. At that time, I felt that it was the psychological properties of THC that would improve her psychological well-being and that a reaction to thoughts about matter would occur to improve her condition. But as I think more about it, I wonder if these patients who were septic actually responded to the CB2 receptor mechanism that would improve their sepsis and allow their bodies to recover. If so, cannabis can be extremely useful for patients trying to recover from a coronavirus infection that causes severe sepsis with organ failure.

I encourage patients to report cannabis use for severe coronavirus infections. If there seems to be no hope of surviving an infection in an elderly patient or in patients with comorbidities that make it difficult to fight the virus, a last resort may be to ingest or inhale THC to reduce and reduce the inflammatory response in severe sepsis and Give the body a chance to recover. These recommendations are based on theory only and not studies. So if you try them out, you do so at your own risk. However, if treatment improves a patient's condition, it should be documented or discussed with health care professionals and reported to the federal government. In this way, if it turns out that cannabinoid receptor agonists like THC are helpful for this condition, the government must immediately change its stance on the marijuana ban to make up for the lost time it has caused in its research and the life we ​​have thereby losing knowledge of the usefulness of THC.

Further reading:
If you are a naturopath or a patient interested in information about medical cannabis, you can pre-order the Clinician & # 39; s Guide to Cannabis, available in June. It is currently only available in digital pre-order, but a paperback version will be available for sale this summer.


Beth Edmonds